Integer Holdings Corporation

NYSE ITGR

Integer Holdings Corporation Net Income for the Trailing 12 Months (TTM) ending September 27, 2024: USD 113.55 M

Integer Holdings Corporation Net Income is USD 113.55 M for the Trailing 12 Months (TTM) ending September 27, 2024, a 37.79% change year over year. Net income is the total profit earned by a company after deducting all expenses, including taxes and non-controlling interest.
  • Integer Holdings Corporation Net Income for the Trailing 12 Months (TTM) ending September 29, 2023 was USD 82.41 M, a 14.38% change year over year.
  • Integer Holdings Corporation Net Income for the Trailing 12 Months (TTM) ending September 30, 2022 was USD 72.05 M, a -18.54% change year over year.
  • Integer Holdings Corporation Net Income for the Trailing 12 Months (TTM) ending October 01, 2021 was USD 88.45 M, a 21.40% change year over year.
  • Integer Holdings Corporation Net Income for the Trailing 12 Months (TTM) ending October 02, 2020 was USD 72.86 M, a -34.40% change year over year.
Key data
Date Net Income EPS (Diluted) Shares (Diluted, Weighted) Net Income Margin
Market news
Loading...
NYSE: ITGR

Integer Holdings Corporation

CEO Mr. Joseph W. Dziedzic
IPO Date Sept. 29, 2000
Location United States
Headquarters 5830 Granite Parkway
Employees 10,500
Sector Health Care
Industries
Description

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through Medical and Non-Medical segments. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

Similar companies

BRKR

Bruker Corporation

USD 61.26

-2.69%

CNMD

CONMED Corporation

USD 67.79

-2.46%

LIVN

LivaNova PLC

USD 47.63

0.66%

IRMD

IRadimed Corporation

USD 57.52

1.79%

NVRO

Nevro Corp.

USD 3.70

-8.19%

ESTA

Establishment Labs Holdings Inc.

USD 33.15

-1.66%

KIDS

OrthoPediatrics Corp.

USD 23.55

-5.80%

TMCI

Treace Medical Concepts, Inc.

USD 8.01

-4.19%

LUNG

Pulmonx Corporation

USD 6.84

-2.98%

IRTC

iRhythm Technologies, Inc.

USD 99.01

4.67%

GKOS

Glaukos Corporation

USD 147.95

-2.58%

OFIX

Orthofix Medical Inc.

USD 17.51

0.81%

NPCE

NeuroPace, Inc.

USD 11.84

-2.23%

StockViz Staff

January 15, 2025

Any question? Send us an email